
Since 2007, the use of zzso agents zzso to treat anemia in cancer patients receiving chemotherapy has been increasingly restricted in the zzso This study assessed zzso zzso decline over time among chemotherapy zzso 

zzso of chemotherapy care were identified in a large zzso electronic medical record zzso weekly zzso levels were zzso in the first 8 zzso zzso and adjusted proportions of zzso with zzso zzso zzso zzso representing clinically significant zzso within 1 or 2 weeks were zzso 

Between 2006 and 2009, zzso proportions of zzso with zzso zzso zzso increased zzso from zzso to zzso zzso from zzso to zzso zzso zzso proportions in 2007 were similar to 2006, but increased in 2008 zzso ratio zzso zzso zzso confidence intervals zzso zzso zzso and in 2009 zzso zzso zzso zzso zzso zzso zzso zzso proportions had the same zzso 

Since restrictions on zzso use were introduced in the USA, more patients have experienced a clinically significant zzso decline after chemotherapy zzso zzso anemia therapy at the earliest indicated opportunity may help reduce the risk of such zzso 

